Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Que

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Journal of Cancer|August 19, 2017
PD-L1 Expression Is Associated with FOXP3+ Regulatory T-Cell Infiltration of Soft Tissue Sarcoma and Poor Patient PrognosisYi Que, Wei Xiao, Yuan-Xiang Guan, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 4, 2025
Royal jelly acid inhibits NF-κB signaling by regulating H3 histone lactylation to alleviate IgE-mediated mast cell activation and allergic inflammationXue-Ting Xu, Jun-Kai Fan, Xi Chen, et al.
Frontiers in Immunology|July 23, 2021
Combination Therapy With Anti-PD-1 or PD-1 Antibody Alone in Asian Pediatric Patients With Relapsed or Refractory CancerYi Que, Juan Wang, Jia Zhu, et al.
Annals of Hematology|January 8, 2022
Efficacy and safety comparison between R-CHOP and modified NHL-BFM-90 regimens in children and adolescents with diffuse large B-cell lymphomaJinqiu Guan, Feifei Sun, Juan Wang, et al.
Cell Death & Disease|April 16, 2022
KDM5B promotes tumorigenesis of Ewing sarcoma via FBXW7/CCNE1 axisBinbin Chen, Huimou Chen, Suying Lu, et al.
International Journal of Oncology|December 8, 2023
The dual HDAC and PI3K inhibitor, CUDC‑907, inhibits tumor growth and stem‑like properties by suppressing PTX3 in neuroblastomaMengzhen Li, Yang Hu, Juan Wang, et al.
Signal Transduction and Targeted Therapy|October 12, 2023
Safety and clinical efficacy of sintilimab (anti-PD-1) in pediatric patients with advanced or recurrent malignancies in a phase I studyYi Que, Juan Wang, Feifei Sun, et al.
Journal of Translational Medicine|December 5, 2024
Genomic and clinical characterization of pediatric lymphoepithelioma-like carcinomaYi Que, Xiuxia Lu, Suying Lu, et al.
Disease Markers|June 27, 2022
Immune-Related LncRNAs as Prognostic Factors for Pediatric Rhabdoid Tumor of the KidneyYe Hong, Yi Que, Yang Hu, et al.
Frontiers in Oncology|October 8, 2021
Irinotecan Plus Doxorubicin Hydrochloride Liposomes for Relapsed or Refractory Wilms TumorJuan Wang, Lian Zhang, Lanying Guo, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Journal of Cancer|August 19, 2017
PD-L1 Expression Is Associated with FOXP3+ Regulatory T-Cell Infiltration of Soft Tissue Sarcoma and Poor Patient PrognosisYi Que, Wei Xiao, Yuan-Xiang Guan, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 4, 2025
Royal jelly acid inhibits NF-κB signaling by regulating H3 histone lactylation to alleviate IgE-mediated mast cell activation and allergic inflammationXue-Ting Xu, Jun-Kai Fan, Xi Chen, et al.
Frontiers in Immunology|July 23, 2021
Combination Therapy With Anti-PD-1 or PD-1 Antibody Alone in Asian Pediatric Patients With Relapsed or Refractory CancerYi Que, Juan Wang, Jia Zhu, et al.
Annals of Hematology|January 8, 2022
Efficacy and safety comparison between R-CHOP and modified NHL-BFM-90 regimens in children and adolescents with diffuse large B-cell lymphomaJinqiu Guan, Feifei Sun, Juan Wang, et al.
Cell Death & Disease|April 16, 2022
KDM5B promotes tumorigenesis of Ewing sarcoma via FBXW7/CCNE1 axisBinbin Chen, Huimou Chen, Suying Lu, et al.
International Journal of Oncology|December 8, 2023
The dual HDAC and PI3K inhibitor, CUDC‑907, inhibits tumor growth and stem‑like properties by suppressing PTX3 in neuroblastomaMengzhen Li, Yang Hu, Juan Wang, et al.
Signal Transduction and Targeted Therapy|October 12, 2023
Safety and clinical efficacy of sintilimab (anti-PD-1) in pediatric patients with advanced or recurrent malignancies in a phase I studyYi Que, Juan Wang, Feifei Sun, et al.
Journal of Translational Medicine|December 5, 2024
Genomic and clinical characterization of pediatric lymphoepithelioma-like carcinomaYi Que, Xiuxia Lu, Suying Lu, et al.
Disease Markers|June 27, 2022
Immune-Related LncRNAs as Prognostic Factors for Pediatric Rhabdoid Tumor of the KidneyYe Hong, Yi Que, Yang Hu, et al.
Frontiers in Oncology|October 8, 2021
Irinotecan Plus Doxorubicin Hydrochloride Liposomes for Relapsed or Refractory Wilms TumorJuan Wang, Lian Zhang, Lanying Guo, et al.
Pageof 6